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In the present study, the NMR spectroscopic features of
trovafloxacin (TVA) mesylate, pefloxacin (PFX) mesylate
dihydrate and ciprofloxacin (CIP) hydrochloride mono-
hydrate were studied in DMSO-d6 solution with the aim
of investigating the effects of substituents and the type
of salt on the NMR parameters of basic bicyclic fluoro-
quinolone and fluoronaphthyridone ring systems. For
this purpose, the 1H- and 13C- one- and two-dimensional
homo- and heteronuclear NMR methods were used. The
analysis of 1H- and 13C-NMR spectra confirmed the struc-
tures of investigated fluoroquinolone salts. Relationships
between 1H- and 13C-NMR chemical shifts of fluorona-
phthyridone and fluoroquinolone ring systems, calcula-
ted molecular descriptors (MDs) and drug-likeness
scores (DLSs), computed for monoprotonic cations of in-
vestigated fluoroquinolone salts (TVAH+, PFXH+ and
CIPH+), were also explored. The topological polar sur-
face area (TPSA), the parameter of lipophilicity
(miLogP), the relative molecular mass (Mr) and the volu-
me (V) of computed molecular descriptors (MDs), as
well as the G protein-coupled receptor ligand-likeness
(GPCR ligand-ls), the ion channel ligand-likeness (ICL-ls),
the kinase inhibitor-likeness (KI-ls) and the nuclear re-
ceptor ligand-likeness (NRL-ls) were used in this study.
The 1H-NMR chemical shifts of protons in COOH, H5
and NHn+, as well as 13C-NMR chemical shifts of C4, C5
and C11 shown to be good parameters in exploration of
property-property and property-drug-likeness relation-
ships for investigated fluoroquinolone salts. Thus, col-
linear relationships of 1H-NMR chemical shifts of pro-
tons in COOH, H5 and NHn+ with TPSA and miLogP, as
well as with GPCR ligand-ls, KI-ls and NRL-ls were re-
vealed (d, ppm H in COOH vs. TPSA, R = –0.9421; d,
ppm H in COOH vs. NRL-ls, R = –0.9216; d, ppm H5 vs.
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Fluoroquinolones are synthetic antibacterial agents, widely prescribed for the treat-
ment of infections in humans, with a broad antibacterial spectrum of activity against
Gram-positive, Gram-negative and mycobacterial pathogens as well as anaerobes. The
bacterial effects of fluoroquinolones inhibit the function of bacterial DNA gyrase and to-
poisomerase IV (1–3). Trovafloxacin (TVA) is a fluoronaphthyridone derivative related
to fluoroquinolones, and it belongs to the class of fourth generation quinolones with a
broad spectrum of antibiotic activity. It has better Gram-positive bacterial coverage and
less Gram-negative coverage than the previous fluoroquinolones, and in comparison
with fluoroquinolones of the third generation, it possesses additional anaerobic cover-
age. Chemically, TVA is 7-[(1R,5S)-6-amino-3-azabicyclo[3.1.0]hexan-3-yl]-1-(2,4-difluo-
rophenyl)-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid. It has been used to treat se-
rious infections, including life-or-limb-threatening infections, pneumonia, complicated
abdominal infections, as well as skin, gynecologic and pelvic infections (4, 5). In compar-
ison with other fluoroquinolones, the pharmacokinetic data for TVA suggests significant
differences in the metabolism and excretion of this agent. Phase II metabolic reactions
for most fluoroquinolones were observed, and the metabolism occurs mainly by oxida-
tive mechanisms [pefloxacin (PFX) and norfloxacin], or the drug is excreted unchanged
in urine [ofloxacin and ciprofloxacin (CIP)], while fecal elimination is the primary route
of TVA excretion in humans. TVA is metabolized primarily by the liver (via
glucuronidation 13.2 %, N-acetylation 10.4 %, and N-sulfoconjugation 4.1 %), and the
role of cytochrome P450 oxidative metabolism seems to be an insignificant route in its
metabolism (6).
Marketing authorisations of TVA mesylate tablets, intended for oral use, and its
prodrug alatrofloxacin mesylate, i.e., L-alanyl-L-alanyl prodrug for infusion, were with-
drawn in 2001, following restriction in 1999 due to hepatotoxicity risk (7). Thus, TVA
shared similar fate at the market as some other fluoroquinolones, which were removed
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miLogP, R = 0.9962; d, ppm H5 vs. KI-ls, R = 0.9969; d,
ppm NHn+ vs. TPSA, R = –0.9875 and d, ppm NHn+ vs.
NRL-ls, R = –0.9948). The collinearities between,
13C-NMR chemical shifts of C4, C5 and C11 with KI-ls
and NRL-ls, as well as with TPSA, miLogP, Mr and V
were also revealed (d, ppm C4 vs. TPSA, R = 0.9964; d,
ppm C4 vs. miLogP, R = 0.9487; d, ppm C4 vs. Mr, R =
0.9629; d, ppm C4 vs. KI-ls, R = 0.9461; d, ppm C4 vs.
NRL-ls, R = 0.9996; d, ppm C5 vs. miLogP, R = 0.9994; d,
ppm C5 vs. KI-ls, R = 0.9990; d, ppm C5 vs. NRL-ls, R =
0.9510; d, ppm C11 vs. TPSA, R = –0,9958; d, ppm C11 vs.
NRL-ls, R = –0.9994 and d, ppm C11 vs. KI-ls, R =
–0.9481).
Keywords: fluoroquinolone antibiotics, trovafloxacin, pe-
floxacin, ciprofloxacin, 1H-NMR spectroscopy, 13C-NMR,
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res, QSAR
or their clinical use was restricted in many countries, e.g., enoxacin (fluoronaphthyrido-
ne derivative), fleroxacin, temafloxacin, grepafloxacin, and newer fluoroquinolones,
sparfloxacin and gatifloxacin. For instance, temafloxacin was withdrawn in 1992 be-
cause of serious adverse drug reactions, including allergic reactions and hemolytic ane-
mia, and grepafloxacin was withdrawn in 1999 due to its side effect of lengthening the
QT interval on the electrocardiogram, leading to cardiac events and sudden death. Like
in the case of temafloxacin, the toxic effects of TVA were not evident until after the drug
was in widespread clinical use.
Recently, the possible mechanisms of TVA hepatotoxicity were discussed in several
papers (8–10). Thus Liguori et al. (2005) used a method of microarray analysis on iso-
lated human hepatocytes by which they clearly distinguished between TVA and other
marketed quinolone agents, and identified unique gene changes induced by TVA that
are involved in mitochondrial damage, RNA processing, transcription, and inflamma-
tion, which may suggest a possible mechanism for the hepatotoxicity induced by this
agent (8). Sun et al. (9, 10) suggested a model of a cyclopropylamine-containing system
that implies oxidation of cyclopropylamine moiety to reactive ring-opened intermedi-
ates with a carbon-centered radical, which can be subsequently converted to a,b-unsatu-
rated aldehyde. They suggested that TVA-induced hepatotoxicity may be mediated by
reactive intermediates that may form covalent adducts to hepatic proteins, resulting in
hepatocyte necrosis and damage to liver tissue. Another possible mechanism of TVA
hepatotoxicity includes the N-acetyl metabolite formation at the primary amino group,
since the site of N-acylation occurs in liver and the N7’-acetyl metabolite was found among
major metabolites in humans together with N7’-sulfate and C11-ester glucuronide. Fur-
ther metabolic reactions of N-acetyl metabolite may result in formation of the eventual
toxin. The full mechanism of TVA hepatotoxicity still remains unresolved (9, 10).
There is a large amount of literature about fluoroquinolones addressing the effect of
modifying each carbon in the molecules of the central bicyclic nucleus (11–13). Nowa-
days, fluoroquinolones with their unique structure and biological activity, as well as the
TVA molecule, still attract the attention of researchers with regard to the synthesis of
new derivatives, new pharmacological activities including antitumor activity, QSAR,
salt formation and complexes with metal cations, clinical usefulness, and the possible
mechanisms of toxicity and structure-side-effect-relationships (14–18). The structures of
fluoroquinolones are directly reflected in their pharmacological effect and side-effect
profiles. In addition to the b-keto-carboxylic group of the quinolone bicyclic ring system
at positions 3 and 4, fluoroquinolones possess a fluorine atom at position C6. While the
b-keto-carboxylic group is responsible for the basic pharmacological activity and acts as
a binding site, the fluorine atom is responsible for cell penetration and gyrase affinity.
Other substituents, positioned at N1 and C7, are responsible for the overall potency and
antibacterial spectrum, and position X8 (X = N) for the antianaerobic spectrum. How-
ever, changes in the basic fluoroquinolone pharmacophore moiety as well as changes in
substituents lead to unexpected adverse reactions, such as the CNS reactions, drug-drug
interactions, phototoxicity, hepatotoxicity and cardiotoxicity such as QTc interval pro-
longation of electrocardiogram, which have been reported in clinical evaluations or the
post-marketing surveillance of several new quinolones (7). Similarly, as found for the
pharmacological effect, the relationships of the structure and adverse effects were ob-
served and specific substituent side effects were revealed (11, 13).
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The aim of this study was to investigate the substituent effects, as well as salt type,
on the basic bicyclic ring systems of TVA mesylate in comparison with PFX mesylate,
and CIP hydrochloride by 1H- and 13C-NMR spectroscopies and to explore the possibil-
ity of NMR chemical shift use in fluoroquinolone antibiotics QSAR studies.
EXPERIMENTAL
Materials
Fluoroquinolones used in this study were donated as reference samples of analyti-
cal grade purity from manufacturers, pharmaceutical companies, i.e., CIP hydrochloride
monohydrate from Krka d.d. (Slovenia), PFX methanesulfonate (mesylate) dihydrate
from Lek d.d. (Slovenia) and TVA mesylate from Pfizer Inc. (USA). For NMR spectro-
scopic measurements, deuterated dimethylsulfoxide-d6 with tetramethysilane (TMS)
(0.03 %), (DMSO-d6), with deuteration degree min. 99.8 % and analytical grade for spec-
troscopy (Merck, Germany), were used without further purification.
NMR studies
The 1H- and 13C- one- and two-dimensional NMR spectra were recorded using a
Varian Gemini 300 spectrometer (Varian, USA) operating at 300 MHz and 75.5 MHz for
the 1H- and 13C- nucleus, respectively. All samples were measured from DMSO-d6 solu-
tions at 20 °C in 5-mm NMR tubes. Chemical shifts (d), in ppm, are referred to TMS as
internal standard, and coupling constants (J) are given in Hz. Digital resolution in
1H-NMR spectra was 0.20 Hz, while it was 0.63 Hz per point in 13C-NMR spectra. The
following spectra were recorded: standard 1H- and 13C- broadband proton decoupled,
13C- gated proton decoupled, APT, COSY-45, NOESY and HECTOR. In all experiments,
the proton decoupled spectrum was performed by Waltz-16 modulation. In two-dimen-
sional experiments, the standard sequence pulse was used. The COSY-45 spectra and de-
layed COSY-45 spectra were measured in the magnitude mode and NOESY spectra in
the »phase sensitive mode«. The COSY-45, the delayed COSY-45 and NOESY spectra
were measured in the magnitude mode using 1024 points in F2 dimension and 256 incre-
ments in F1 dimension, subsequently zero-filled to 1024 points. Each increment was ob-
tained with 16 scans, 3000 Hz spectral width and relaxation time delay of 1 s. The corre-
sponding digital resolution was 5.9 Hz/point and 11.7 Hz/point for F2 and F1 dimen-
sions, respectively. The NOESY spectrum was measured with several time lapses
(0.45–1.2 s). The HECTOR spectrum was recorded with 2048 points in F2 dimension and
256 increments in F1 dimension, zero-filled to 512 points. Increments were recorded
with 64 scans, relaxation time of 1 s and spectral width of 20000 Hz in F2 and 4500 Hz in
F1 dimension. The corresponding digital resolution was 19.53 and 17.6 Hz/point in F2
and F1 dimensions, respectively.
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Computation and data processing
Lipinski’s rule-of-five analysis and parameters (miLogP, Mr, TPSA, n atoms, n ON,
n OHNH, n rotatable bonds, volume) as well as drug-likeness scores for GPCR ligand,
ion channel modulator, kinase inhibitor and nuclear receptor ligand were calculated us-
ing Molinspiration molecular processing engine, version 2007.10. (19–22). Molinspira-
tion molecular processing data were calculated for the cationic part of each investigated
fluoroquinoline salt, i.e., trovafloxacin mesylate cation (TVAH+), pefloxacin mesylate
cation (PFXH+) and ciprofloxacin hydrochloride cation (CIPH+) at the presumption that
salt formation occurred on the nitrogen atom N4’ in the piperazine ring of pefloxacin
and ciprofloxacin molecule and at the amino group in TVAmolecule. The simplified mo-
lecular input line entry system (SMILES) and calculated parameters (Table I) for each
fluoroquinolone cation are as follows:
ciprofloxacin cation (CIPH+ or RR’NH2+):
SMILES [H][N+]4([H])CCN(c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C3CC3)CC4;
pefloxacin cation (PFXH+ or RR’R’’NH+):
SMILES [H][N+]3(C)CCN(c1cc2c(cc1F)c(=O)c(C(=O)O)cn2CC)CC3;
trovafloxacin cation (TVAH+ or RNH3+):
SMILES [H][N+]([H])([H])C5C4CN(c1nc2c(cc1F)c(=O)c(C(=O)O)cn2c3ccc(F)cc3F)CC45.
All analyses were performed and data were graphed using the OriginPro 7.5 soft-
ware (Origin Laboratories, USA).
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Table I. Calculated molecular descriptors (MDs) and drug-likeness scores (DLSs) for investigated
fluoroquinolone cations
Calculated
parameter
Ciprofloxacin
cation (CIPH+
or RR’NH2+)
Pefloxacin
cation (PFXH+
or RR’R’’NH+)
Trovafloxacin
cation (TVAH+
or RNH3+)
Molecular
descriptors
(MDs)
miLogP –3.365 –3.255 –1.936
TPSA 79.147 66.978 103.076
n atoms (without H) 24 24 30
Relative molecular mass (Mr) 332.355 334.371 417.367
n ON 6 6 7
n OHNH 3 2 4
n violations 0 0 0
n rotatable bonds 3 3 3
Volume (V) 286.436 299.289 328.708
Drug-likeness
scores (DLSs)
GPCR ligand 0.11 –0.07 –0.02
Ion channel modulator 0.45 0.21 –0.23
Kinase inhibitor –0.30 –0.27 0.05
Nuclear receptor ligand –0.73 –0.81 –0.53
RESULTS AND DISCUSSION
In this study, TVA mesylate, PFX mesylate and CIP hydrochloride belonging to the
fourth, third and second generation of quinolone antibiotics, respectively, were investi-
gated (Fig. 1).
The primary aim of this study was to explore in more detail the NMR spectroscopic
features of these antibiotic structures, as well as the impact of different substituents on
1H- and 13C-NMR chemical shifts of basic bicyclic ring systems as possible parameters
in fluoroquinolone QSAR studies. For this purpose, the 1H- and 13C-NMR spectra of
TVA mesylate, PFX mesylate dihydrate and CIP hydrochloride monohydrate (Table I)
were recorded in DMSO-d6 solution.
Structures of the investigated fluoroquinolone salts were investigated by means of
NMR spectroscopy, using 1H- and 13C- one- and two-dimensional homo- and heteronu-
clear NMR methods. Analyses of spectra were performed on the basis of NMR parame-
ters, i.e. chemical shifts (d/ppm) and coupling constants H-H, F-H, C-H and C-F (J/Hz),
as well as using the NMR substituent effects, intensities and multiplicities of signals (split-
ting patterns) in their one-dimensional 1H- and 13C-NMR spectra and contours in 2D
spectra.
The 1H- and 13C-NMR spectral data for each fluoroquinolone salt are displayed in
Tables II and III, respectively. The NOESY spectrum of TVA mesylate is shown in Fig. 2,
and the 13C-NMR spectrum in Fig. 3. Obtained results are in good agreement with previ-
ously published data for these fluoroquinolones in the zwitter-ion or free base form (17,
24, 25).
In contrast to the PFX and CIP basic bicyclic ring system, i.e., fluoroquinolone moi-
ety, trovafloxacin is a fluoronaphthyridone derivative and it differs in the nitrogen atom
at position 8, instead of a carbon atom in bicyclic ring system of the other two fluoro-
quinolones (Fig. 1). This change in the basic ring system contributes to the overall elec-
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Fig. 1. Structures of investigated TVA mesylate, PFX mesylate and CIP hydrochloride.
tron distribution in trovafloxacin molecule, and not only to substituents at positions 1
and 7. The 2,4-difluoro-1-phenyl substituent at position N1 and 6-amino-3-azabicyclo-
[3.1.0]hexan-3-yl substituent at position C7 in TVAmolecule make additional differences
compared to substituents at these positions in PFX (ethyl and 4’-methyl-1’-piperazinyl)
and in CIP (cyclopropyl and piperazinyl) molecules. Furthermore, TVA possesses a pri-
mary amino group, which is not usually present in other fluoroquinolones either in clin-
ical use or among the withdrawn drugs of this group.
Structural differences in TVA compared to PFX and CIP molecule influence in a spe-
cific way its physicochemical properties, pharmacological activity, pharmacokinetic and
side-effect profile. Therefore, it is expected that these structural changes also affect the
NMR spectroscopic features of basic bicyclic ring systems of investigated fluoroquino-
lone salts.
1H-NMR spectroscopy
The 1H-NMR spectra of investigated fluoroquinolones showed characteristic signals
for aromatic and non-aromatic protons in their molecules. Carboxylic protons (COOH)
in the spectra of TVA mesylate, PFX mesylate and CIP hydrochloride were observed
downfield in the corresponding spectra as singlets (1H) at d 15.06, 15.28 and 15.15 ppm,
respectively. The decrease of chemical shifts was observed in the following order: PFX
mesylate > CIP hydrochloride > TVA mesylate. It is interesting to note that in the spec-
trum of CIP (free base), also investigated in the broader frame of this study, the carbo-
xylic proton was not observed up to d 20 ppm, either in 1H-NMR spectra of concentrated
or diluted DMSO-d6 solutions of CIP. These findings indicate that CIP in the free base
form exists in the form of zwitterion in DMSO-d6 solution, independently of CIP concen-
tration.
For the aromatic part of 1H-NMR spectra, the characteristic splitting pattern due to
the presence of fluorine atom at C6, and additionally in TVAmesylate, at C2’’ and C4’’ in
2,4-difluorophenyl substituent, allowed a simple assignation of protons H5 and H8 of
the basic fluoroquinolone ring system and protons H3’’, H5’’ and H6’’ in TVA mesylate.
The H5 protons in 1H-NMR spectra of TVA mesylate, PFX mesylate and CIP hydrochlo-
ride were at d 8.07, 7.97 and 7.95 ppm, respectively, and appear as doublets split by the
fluorine atom through three bonds and with the corresponding coupling constants 3JH-F
= 12.3, 3JH-F = 13.1 and 3JH-F = 13.1 Hz. The signal of protons H8 in PFX mesylate and
CIP hydrochloride were at d 7.29 and 7.61 ppm, split through four bonds by the fluorine
atom into doublets with coupling constants 4JH-F = 7.1 and 4JH-F = 7.3 Hz, respectively,
while this signal was missing in the TVA mesylate 1H-NMR spectrum due to the
fluoronaphthyridone bicyclic ring system, where X at position 8 is represented by N
atom.
The H2 protons in 1H-NMR spectra of TVAmesylate, PFX mesylate and CIP hydro-
chloride were observed as singlets (1H) at 8.83, 8.98 and 8.69 ppm, respectively. The H2’
and H4’ protons in 1H-NMR spectrum of TVA mesylate are observed as a broad mul-
tiplet signal (4H) at d 3.67, while H1’ and H5’ protons are displayed as a singlet (2H) at
2.08 ppm.
The protons of protonated primary, secondary and tertiary amino moieties in the
corresponding fluoroquinolone salts, i.e., RNH3+ in TVAH+, RR’NH2+ in CIPH+, and
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RR’R’’NH+ in PFXH+, were observed as broad singlet (bs) signals in their 1H-NMR spec-
tra and are as follows: d 8.18 ppm (3H) for RNH3+ in TVAmesylate 1H-NMR spectrum, d
9.55 ppm (2H) in CIP hydrochloride 1H-NMR spectrum and d 9.87 ppm (1H) in PFX
mesylate 1H-NMR spectrum.
All non-aromatic protons were observed upfield in the corresponding 1H-NMR
spectra of related fluoroquinolone, and their chemical shifts, splitting patterns and cou-
pling constants (3JH-H) are shown in Table II.
13C-NMR spectroscopy
The 13C-NMR proton decoupled spectra of investigated fluoroquinolone salts recor-
ded in DMSO-d6 solutions showed the characteristic splitting pattern due to the pres-
ence of fluorine atom at C6, and additionally two fluorine atoms, C2’’ and C4’’, in the
difluorophenyl substituent at N1 in TVA mesylate. The splitting of carbon signals with
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Table II. 1H-NMR spectral data, chemical shifts, multiplicites, number of protons and coupling constants
of TVA mesylate, PFX mesylate and CIP hydrochloride, recorded in DMSO-d6 solution
H-atom
1H-NMR chemical shifts (d, ppm, multiplicity and coupling constants
(nJH-F and nJH-H in Hz)
Trovafloxacin mesylate Pefloxacin mesylate Ciprofloxacin hydochloride
COOH 15.06, s, 1H 15.28, s, 1H 15.14, bs, 1H
2 8.83, s, 1H 8.98, s, 1H 8.69, s, 1H
5 8.07, d, 1H, 3JH-F = 12.3 7.97, d, 1H, 3JH-F = 13.1 7.95, d, 1H, 3JH-F = 13.1
8 – 7.29, d, 1H, 4JH-F = 7.1 7.61, d, 1H, 4JH-F = 7.3
1’ 2.08, s, 1H – –
2’ 3.67, m, 2H 3.32, s, 2H H2’, H6’ 3.33, s, 4H
3’ – 3.90, s, 2H H3’, H5’, 3.59, s, 4H
4’ 3.67, m, 2H –
5’ 2.08, s, 1H 3.90, s, 2H H4’(N) – displayed
under NHn+6’ 3.37, s, 1H 3.32, s, 2H
NHn+ 8.18, bs, 3H 9.87, bs, 1H 9.55, bs, 2H
CH3-N4’ – 2.36, s, 3H –
1’’ – 4.63, q, 2H, 3JH-H = 6.8 3.88, bs, 1H
2’’ – 1.43, t, 3H, 3JH-H = 6.9 1.34, d, 2H, 3JH-H = 6.4
3’’ 7.62, td, 1H, 3JH-F = 8.6 – 1.21, bs, 2H
4’’ – – –
5’’ 7.37, td, 1H, 3JH-F = 8.6 – –
6’’ 7.85–7.78, m, 1H – –
CH3a 2.45, s, 3H 2.92, s, 3H –
a CH3 in mesylate moiety, s – singlet, bs – broad singlet, d – doublet, t – triplet, td – triplet of doublets,
q – quartet, m – multiplet
fluorine atoms was observed through one, two, three and four bonds in these molecules.
The splitting of carbon signals through one bond was observed for C6 in all investigated
fluoroquinolones, and additionally for C2’’ and C4’’ atoms in TVA mesylate (Fig. 3). Che-
mical shifts, multiplicities of signals and coupling constants (nJC-F and nJC-H in Hz) for
investigated salts are given in Table III. In correlation studies with molecular descriptors
and drug-likeness scores, the 13C-NMR chemical shifts of selected carbon atoms from
the basic bicyclic ring system, i.e., C4, C5 and C11, were used. An average 13C-NMR
chemical shift (d, ppm) of the basic fluoroquinolone ring system in each fluoroquinolone
salt was calculated by summing up all C signal lines observed in their spectra, belonging
to C2 to C10 including the signal for carboxylic C11, and by dividing the resulting sum by
the number of signal lines [S signal lines/n signal lines]. The average of 13C-NMR chem-
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mesylate.
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Fig. 3. The 13C-NMR spectrum of TVA mesylate.
ical shifts for the basic fluoroquinolone moiety, including the corresponding C11, was
further used as an additional 13C-NMR parameter in correlation with computed molecu-
lar descriptors (MDs) and drug-likeness scores (DLSs).
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Table III. 13C-NMR spectral data, chemical shifts, multiplicities of signals and coupling constants of TVA
mesylate, PFX mesylate and CIP hydrochloride, recorded in DMSO-d6 solution
C-atom
13C-NMR chemical shifts (d, ppm), multiplicity and coupling constants
(nJC-H and nJC-F in Hz)
Trovafloxacin
mesylate
Pefloxacin
mesylate
Ciprofloxacin
hydochloride
C11 165.38, s 166.13, s 165.94, s
2 148.02, s 148.86, s 148.28, s
3 108.94, s 107.28, s 106.95, s
4 177.05, d, 4JC-F = 2.5 176.24, s 176.45, d, 4JC-F = 3.4
5 117.88, d, 2JC-F = 21.2 111.52, d t, 2JC-F = 22.7 111.27, d, 2JC-F = 22.8
6 162.65, d, 1JC-F = 249.0 152.81, d, 1JC-F = 249.2 152.97, d, 1JC-F = 249.3
7 148.86, d, 2JC-F = 13.0 144.02, d, 2JC-F = 10.6 144.24, d, 2JC-F = 10.1
8 – 106.80, t, 3JC-F = 36.2 106.97, 3JC-F = 3.8
9 130.95, d, 3JC-F = 10.2 120.12, d, 3JC-F = 7.4 119.42, d, 3JC-F = 7.6
10 146.07, s 137.19, s 139.20, s
1’ 20.68, m – –
2’ 49.97, s
C2’,C6’ 46.74, td, 2C,
1JC-H = 140.9, 4JC-F = 4.7
C3’,C5’ 42.38, s, 2C
C2’,C6’ 46.48, td, 2C,
1JC-H = 141.1, 4JC-F = 4.8
C3’,C5’ 42.59, t, 2C,
1JC-H = 139.9
3’ –
4’ 49.97, s
5’ 21.11, m
6’ 49.73, s
CH3-N4’- – 49.24, s –
1’’
124.20, dd,
3JC-F = 3.7 and 3.9
52.27, s 36.10, d, 1JC-H = 187.8
2’’ 146.11, d, 1JC-F = 259.1 14.64, s C2’’,C3’’ 7.73, t, 2C,
1JC-H = 165.93’’
104.88, dd,
2JC-F = 24.2 and 27.3
–
4’’ 157.33, d, 1JC-F = 252.55 – –
5’’ 112.32, dd 2JC-F = 3.3 – –
6’’ 110.77, d, 2JC-F = 3.4 – –
CH3 a 31.33, s 35.31, s –
a CH3 in mesylate moiety, s – singlet, d – doublet, dd – doublet of doublets, t – triplet, td – triplet of doublets,
m – multiplet
Correlation studies
The selected 1H- and 13C-NMR chemical shifts (d/ppm) of H and C atoms, belong-
ing to basic fluoronaphthyridone and fluoroquinolone moieties, including atoms in COOH
and NHn+ (Table IV), and the MDs, i.e., the lipophilicity parameter (miLogP), the topo-
logical polar surface area (TPSA), the relative molecular mass (Mr) and the volume (V),
as well as DLSs for specific biological activity, i.e., the G protein-coupled receptor ligand
likeness (GPCR ligand-ls), the ion channel modulator likeness (ICM-ls), the kinase inhib-
itor likeness (KI-ls) and the nuclear receptor ligand likeness (NRL-ls) (Table V), were used
in the study.
MDs and DLSs were calculated for the monocharged cations of investigated fluoro-
quinolone salts, i.e., the pefloxacin cation (PFXH+), where tertiary N4’ in methylpipera-
zine ring is protonated (RR’R’’NH+), the ciprofloxacin cation (CIPH+) with positive char-
ge at N4’, where the secondary amino group in piperazine ring at N4’ is protonated (RR’
NH2+), and for trovafloxacin cation (TVAH+), where the primary amino group at posi-
tion C6’ is protonated (RNH3+). Thus, the investigated fluoroquinolone salts were repre-
sented as primary, secondary or tertiary amine salts.
Relationships between the selected NMR chemical shifts (d, ppm), MDs and DLSs,
as well as the collinearity parameters are shown in Table VI. In general, the 13C-NMR
chemical shifts (d, ppm) showed collinearities with more investigated MDs and DLSs
than the selected 1H-NMR chemical shifts (d, ppm).
1H-NMR chemical shift correlations
Among investigated 1H-NMR chemical shifts collinearities were revealed with d/ppm
of H5, H in COOH and NHn+, while the H2 d/ppm showed no collinearity with the in-
vestigated DSs and DLSs.
Chemical shifts of H5, increased in the order CIPH+, PFXH+ to TVAH+ and collinear
relationships with miLog P and KI-ls (R = 0.9962 and R = 0.9969, respectively), were re-
vealed. However, the 1H-NMR chemical shifts of protons in COOH and NHn+ showed
the upfield chemical shift in the order PFXH+, CIPH+ to TVAH+, which is in line with
types of salts, i.e., tertiary, secondary and primary amine salts, and collinearities between
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Table IV. Selected 1H- and 13C-NMR chemical shifts of the corresponding fluoroquinolone salts used in
correlatons with molecular descriptors (MDs) and drug-likeness scores (DLSs)
Compd.
Selected NMR chemicl shifts (d, ppm)
13C-NMR 1H-NMR
C2 C4 C5 C11 COOH NHn+ H2 H5
CIP HCl 148.28 176.45 111.27 165.94 15.14 9.55 8.69 7.95
PFX Mes 148.86 176.24 111.52 166.13 15.28 9.87 8.98 7.97
TVA Mes 148.02 177.05 117.88 165.38 15.06 8.18 8.83 8.07
248
M. Jadrijevi}-Mladar Taka~: Effects of substituents on the NMR features of basic bicyclic ring systems of fluoroquinolone antibiotics
and the relationships between NMR chemical shifts, molecular descriptors and drug-likeness parameters, Acta Pharm. 60 (2010) 237–254.
Table V. Calculated molecular descriptors (miLogP, TPSA, Mr and V) and drug-likeness scores (GPCR
ligand-ls, ICM-ls, KI-ls and NRL-ls) for monoprotonated cations of investigated fluoroquinolone salts
Cation
Molecular descriptors (MDs) Drug-likeness scores (DLSs)
miLogP TPSA Mr V
GPCR
ligand-ls
ICM-ls KI-ls NRL-ls
CIPH+ –3.365 79.147 332.355 286.436 0.11 0.45 –0.30 –0.73
PFXH+ –3.255 66.978 334.371 299.289 –0.07 0.21 –0.27 –0.81
TVAH+ –1.936 103.076 417.367 328.708 –0.02 –0.23 0.05 –0.53
miLogP – lipophilicity parameter, TPSA – total polar surface area, Mr – relative molar mass, V – volume,
GPCR ligand-ls – G protein-coupled receptor ligand likeness score, ICM-ls – ion channel modulator likeness,
KI-ls – kinase inhibitor likeness score
Table VI. Investigated collinearities between 1H- and 13C-NMR chemical shifts (d, ppm), molecular
descriptors (TPSA, miLogP, Mr and V) and computed drug-likeness scores with drugs of known
biological activity, GPCR ligand-ls, ICM-ls, KI-ls and NRL-ls
No. Parameter 1 Parameter 2 Y = A + Bx R SD P
1 miLogP Mr Y = 535.1466 + 60.9335X 0.9988 3.3219 0.0308
2 miLogP TPSA Y = 143.5583 + 21.2102X 0.9184 10.2792 0.2590
3 1H d, ppm COOH TPSA Y = 15.6345 – 0.0057X 0.9421 0.0528 0.2178
4 1H d, ppm COOH NRL-ls Y = 17.4042 – 1.1936X –0.9216 0.0792 0.2539
5 13C d, ppm C11 TPSA Y = 167.5729 – 0.0211X –0.9958 0.0504 0.0503
6 13C d,ppm C11 ICM-ls Y = –120.7745 + 0.7292X 0.8245 0.2760 0.3829
7 13C d, ppm C11 KI-ls Y = 78.0452 – 0.4717X –0.9481 0.0872 0.2060
8 13C d, ppm C11 NRL-ls Y = 60.6051 – 0.3697X –0.9994 0.0071 0.0222
9 13C d, ppm C4 TPSA Y = 174.6856 + 0.0228X 0.9964 0.0506 0.0543
10 13C d, ppm C4 miLogP Y = 178.0103 + 0.5015X 0.9487 0.1880 0.2048
11 13C d, ppm C4 Mr Y = 173.5648 + 0.0083X 0.9629 0.1604 0.1740
12 13C d, ppm C4 V Y = 171.6466 + 0.0162X 0.8547 0.3086 0.3475
13 13C d, ppm C4 KI-ls Y = –77.27094 + 0.4366X 0.9461 0.0889 0.2100
14 13C d, ppm C4 NRL-ls Y = –61.2489 + 0.3429X 0.9996 0.0058 0.0182
15 1H d, ppm H5 miLogP Y = 8.2264 + 0.0806X 0.9962 0.0079 0.0554
16 1H d, ppm H5 KI-ls Y = –24.2278 + 3.0081X 0.9969 0.0216 0.0502
17 13C d, ppm C5 miLogP Y = 126.9841 + 4.7081X 0.9994 0.1899 0.0228
18 13C d, ppm C5 KI-ls Y = –6.0481 + 0.0517X 0.9990 0.0121 0.0280
19 13C d, ppm C5 NRL-ls Y = 130.6010 + 24.7019X 0.9510 1.6384 0.2002
20 1H d, ppm NHn+ TPSA Y = 13.2095 + 0.0483X –0.9875 0.2004 0.1009
21 1H d, ppm NHn+ NRL-ls Y = 0.7804 – 0.1598X –0.9948 0.0207 0.0648
22 1H d, ppm NHn+ ICM-ls Y = –2.8978 + 0.3306X 0.8605 0.2485 0.3403
TPSA – topological polar surface area, miLogP – logarithm of partition coefficient, Mr – relative molecular
mass, G protein-coupled receptor-likeness score (GPCR ligand-ls), ion channel modulator-likeness (ICM-ls),
kinase inhibitor-likeness (KI-ls) and nuclear receptor ligand-likeness (NRL-ls)
the 1H-NMR chemical shift of H in COOH and NHn+with TPSA (R = –0.9421 and R = –0.9875,
respectively) and with NRL-ls (R = –0.9216 and R = –0.9948, respectively) were revealed
(Table VI).
In the investigated relationships, using the selected 1H-NMR chemical shifts, the in-
fluence of substituents at positions 1 (R1) and 7 (R2), as well as X8 = N, on the chemical
shifts of H5 was observed, so that the experimental parameters are in collinear relation-
ships with the miLogP and KI-ls. Significant differences in TVAH+ parameters, compa-
red to PFXH+ and CIPH+ parameters, were also observed.
13C-NMR chemical shift correlations
The 13C-NMR chemical shifts of selected C atoms, which belong to the basic bicyclic
fluoronaphthyridone and fluoroquinolone systems, C4, C5 and C11 from the COOH
group, showed collinearities with MDs and DLSs. Thus, the 13C NMR chemical shifts of
C4, C5 and C11 showed collinearities with TPSA, miLogP, as well as with KI-ls and
NRL-ls, while the C2 d, ppm showed no collinearities in correlations with the investi-
gated MDs and DLSs.
In addition to findings for 1H-NMR of H5, the 13C-NMR chemical shifts of C5
showed also collinearities with miLogP and KI-ls (R = 0.9994 and R = 0.9990, respec-
tively). Due to impact of substituents in TVAH+, the d, ppm of C5 significantly differs
from C5 in PFXH+ and CIPH+, as well as in relative drug-likeness score for KI-ls. Simi-
larly to findings for H5 and C5, in their collinearities with miLogP and KI-ls, the H in
COOH d, ppm and C11 d, ppm revealed collinearities with TPSA and NRL-ls (R = –0.9958
and R = –0.9994, respectively); however, the d, ppm of H in COOH showed no signifi-
cance in correlations with TPSA and NRL-ls (Table VI).
Among the chemical shifts used in this investigation, the C4 d, ppm showed colli-
nearities with different MDs and DLSs, i.e., TPSA, miLogP, Mr, NRL-ls and KI-ls. Thus,
the following collinearities were revealed with TPSA and NRL-ls (R = 0.9964 and R =
0.9996, respectively) while the other collinear relationships were with miLogP, KI-ls and
Mr (R = 0.9487, R = 0.9461 and R = 0.9629, respectively) (Table VI).
The investigated 1H- and 13C-NMR chemical shifts in correlations with volume (V)
and other DLSs (ICM-ls and GPCR-ligand-ls) showed no collinearities. The only collinear
relationship with GPCR ligand-ls was revealed with an average 13C-NMR chemical shift
of the basic bicyclic ring systems (FQbbrs), R = 0.9873). FQbbrs was obtained by sum-
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Table VII. Investigated relationships of molecular descriptors (MDs) and drug-likeness scores (DLSs)
with the corresponding 1H and 13C chemical shifts
MDs or DLs 1H-NMR 13C-NMR
TPSA NHn+, H in COOH C4 and C11
miLogP H5 C4 and C5
NRL-ls NHn+and H in COOH C4, C5 and C11
KI-ls H in COOH and H5 C4, C5 and C11
ming up all signal lines that belong to fluoronaphthyridone or fluoroquinolone C atoms
(C2 to C10) including C11 from carboxylic group, and by dividing the resulting sum by
the number of lines (S of ppm of all signal lines C2-C10 and C11/n of signal lines).
The overall findings of investigations of the relationships between MD and DLS
with the corresponding 1H- and 13C-NMR chemical shifts are given in Tables VI and VII,
and schematically in Fig. 4, while the corresponding 1H- and 13C-NMR chemical shifts in
relationships with a particular fluoroquinolone salt (primary, secondary or tertiary ami-
ne salt) are displayed in Table VIII.
The change in TPSA of investigated fluoroquinolone salts affects the 1H-NMR che-
mical shifts of NHn+ and H in COOH, as well as the 13C-NMR chemical shifts of C4 and
C11, the atoms included in keto-carboxyilic moiety responsible for the fluoroquinolone
binding site. The order of chemical shifts, PFXH+ > CIPH+ > TVAH+ was observed for
NHn+ protons (i.e., 9.87, 9.56 and 8.18, respectively) as well as for the corresponding pro-
ton in their COOH groups (i.e., 15.28, 15.14 and 15.06), indicating upfield shifts of these
protons from tertiary, secondary to primary amine salts. The same order, i.e., PFXH+ >
CIPH+ > TVAH+ (tertiary > secondary > primary amine salt) was revealed for NRL-ls. In
conclusion, the type of salt and TPSA have an important role for the fluoroquinolone
binding site and NRL-ls of investigated fluoroquinolone salts.
Collinear relationships were also revealed between miLogP and 1H-NMR chemical
shifts of H5 and 13C-NMR chemical shifts of C5. While the downfield shift was observed
for H5, in the order TVAH+ > CIPH+ > PFXH+ (i.e., primary > secondary > tertiary amine
salt), the 13C-NMR chemical shifts of C5 were in the order TVAH+ > PFXH+ > CIPH+
(primary > tertiary > secondary amine salt). However, the 1H- and 13C-NMR chemical
shifts of H5 and C5 showed collinearities with KI-ls. Therefore, regardless of the order
related to the type of salt, the NMR chemical shifts of H5 and C5 could be useful in fur-
ther correlation studies with miLogP and KI-ls of fluoroquinolone antibiotics.
Findings in this study showed differences in experimental and computed parame-
ters for TVA mesylate in comparison with PFX mesylate and CIP hydrochloride, which
could be related to different side-effect profiles of these fluoroquinolones.
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Table VIII. Chemical shifts (d, ppm) in relationships with fluoroquinolone type of amine salt
1H- or 13C-NMR
d, ppm
Chemical shift (d, ppm)
decreasing
Type od amine salt
(RNH3+, RR’NH2+, RR’R’’NH+)
NHn+ PFXH+ > CIPH+ > TVAH+ tertiary > secondary > primary
H5 TVAH+ > PFXH+ > CIPH+ primary > tertiary > secondary
H in COOH PFXH+ > CIPH+ > TVAH+ tertiary > secondary > primary
C4 TVAH+ > CIPH+ > PFXH+ primary > secondary > tertiary
C5 TVAH+ > PFXH+ > CIPH+ primary > tertiary > secondary
C11 PFXH+ > CIPH+ > TVAH+ tertiary > secondary > primary
CONCLUSIONS
By correlating 1H- and 13C-NMR chemical shifts of H and C atoms of fluoroquino-
lones basic ring systems with calculated molecular descriptors Mr, TPSA, miLogP and
V), as well as with drug-likeness scores (GPCR, ICL-ls, KI-ls and NRL-ls) computed for
monoprotonic cations of investigated fluoroquinolone salts (TVAH+, PFXH+ and CIPH+),
collinear relationships were revealed between investigated parameters.
The 13C-NMR chemical shifts of C4, C5 and C11 and the 1H-NMR chemical shifts of
COOH, H5 and NHn+ protons proved to be good parameters in exploration of property-
-property and property-drug-likeness relationships between investigated fluoroquinolo-
ne salts. Thus, collinearities between 13C-NMR chemical shifts of C4, C5 and C11 and
KI-ls and NRL-ls, respectively in addition to TPSA, miLogP andMr were revealed, while
the 1H-NMR chemical shifts of COOH, H5 and NHn+ protons showed collinearity with
TPSA and miLogP, as well as with KI-ls, NRL-ls and GPCR ligand-ls.
Although significant collinearities between the investigated parameters of these fluo-
roquinolones were revealed, the findings of this study also showed differences in experi-
mental and computed parameters for TVA mesylate in comparison with PFX mesylate
and CIP hydrochloride, which could be related to different side-effect profiles of these
fluoroquinolones.
For the use of NMR parameters in prediction of relationships either with MDs or
DLSs with the aim of predicting the biological activity or safety profiles of fluoroqui-
nolone antibiotics, more fluoroquinolone antibiotics should be included into investigation.
Acronyms. – APT – attached proton test; CIP – ciprofloxacin; CIPH+ – monoprotonated
ciprofloxacin cation; CNS – central nervous system; COSY – correlated spectroscopy;
DLS – drug-likeness score; DMSO-d6 – deuterated dimethylsulfoxide; FQ – fluoroquino-
lone; GPCR ligand – G protein-coupled receptor ligand; GPCR ligand-ls – GPCR ligand
likeness score; HECTOR – heteronuclear chemical shift correlation; ICM – ion channel
modulator; ICM-ls – ion channel ligand likeness score; KI – kinase inhibitor; KI-ls – ki-
nase inhibitor likeness score; MD – molecular descriptor; miLogP – molinspiration loga-
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Fig. 4. The shematic display of investigated fluoroquinolone salt structures with marked H and C
atoms whose 1H- and 13C-NMR chemical shifts showed collinear relationships [(R = d (0.9–1.0)] with the
corresponding MDs and DLSs.
rithm of lipophilicity; Mr – relative molecular mass; NMR – nuclear magnetic resonance;
NOESY – nuclear Overhauser and exchange spectroscopy; NRL – nuclear receptor li-
gand; NRL-ls – nuclear receptor ligand likeness score; PFX – pefloxacin; PFXH+ –
monoprotonated pefloxacin cation; P – statistical parameter; R – coefficient correlation;
RNA – ribonucleic acid; QSAR – quantitative structure activity relationship; QTc interval
– a measure of the time between the start of the Q wave and the end of the T wave in the
heart’s electrical cycle; SD – standard deviation; TPSA – topological polar surface area;
TVA – trovafloxacin; TVAH+ – monoprotonated trovafloxacin cation; V – volume.
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S A @ E T A K
Utjecaj supstituenata na NMR zna~ajke temeljnog bicikli~kog prstenastog sustava
fluorokinolonskih antibiotika i odnos izme|u NMR kemijskih pomaka,
molekulskih opisiva~a i parametara sli~nosti s lijekovima
MILENA JADRIJEVI]-MLADAR TAKA^
U radu je opisano ispitivanje NMR spektroskopskih zna~ajki trovafloksacin (TVA)
mesilata, pefloksacin (PFX) mesilata i ciprofloksacin (CIP) hidroklorida u DMSO-d6 oto-
pini s ciljem da se istra`i utjecaj supstituenata i tipa soli na NMR parametre bicikli~kog
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fluorokinolonskog i fluoronaftiridonskog prstenastog sustava. Analizom jedno- i dvo-di-
menzijskih, homo- i hetero-nuklearnih 1H- i 13C-NMR spektara potvr|ena je struktura
ispitivanih fluorokinolonskih soli.
1H- i 13C-NMR kemijski pomaci temeljnih prstenastih sustava korelirani su s izra~u-
natim molekulskim opisiva~ima (relativnom molekulskom masom, Mr, topologijskom
polarnom povr{inom, TPSA, lipofilno{}u, miLogP i volumenom, V) te s parametrima
sli~nosti s lijekovima poznate biolo{ke aktivnosti, tj. s ligandom G protein-spregnutog
receptora (GPCR ligand), ligandom ionskih kanala (ICL), inhibitorom kinaze (KI) i ligan-
dom nuklearnog receptora (NRL) koji su izra~unati za monoprotonske katione ispitiva-
nih fluorokinolonskih soli (TVAH+, PFXH+ and CIPH+).
13C-NMR kemijski pomaci C4, C5 i C11 atoma i 1H-NMR kemijski pomaci protona u
COOH, H5 i NHn+ ispitivanih fluorokinolonskih soli pokazali su se kao dobri parametri
za istra`ivanje odnosa svojstvo-svojstvo i svojstvo-sli~nost s lijekovima poznate biolo{ke
aktivnosti. Tako je otkriven kolinearan odnos izme|u 13C-NMR kemijskih pomaka C4, C5
i C11 atoma i izra~unatih parametara za sli~nost s KI-ls i NRL-ls, kao i kolinearnost s
TPSA, miLogP, Mr i V (C4 d, ppm s TPSA, R = 0,9964; C4 d, ppm s miLogP, R = 0,9487;
C4 d, ppm s Mr, R = 0,9629; C4 d, ppm s V, R = 0,8547; C4 d, ppm s KI-ls, R = 0,9461 i C4
d, ppm s NRL-ls, R = 0,9996; C5 d, ppm s miLogP, R = 0,9994; C5 d, ppm s KI-ls, R =
0,9990 i C5 d, ppm s NRL-ls, R = 0,9510; C11 d, ppm s TPSA, R = –0,9958; C11 d, ppm s
KI-ls, R = –0,9481 i C11 d, ppm s NRL-ls, R = –0,9994).
1H-NMR kemijski pomaci protona COOH, H5 i NHn+ pokazali su kolinearnost
odnosa s TPSA i miLogP, te s izra~unatim parametrima za KI-ls, NRL-ls i GPCRl-ls (d,
ppm H u COOH s TPSA, R = –0,9421; d, ppm H u COOH s NRL-ls, R = –0,9216; H5 d,
ppm s miLogP, R = 0,9962; d, ppm H5 s KI-ls, R = 0,9969; d, ppm NHn+ s TPSA, R =
–0,9875; d, ppm NHn+ s NRL-ls, R = –0,9948; d, ppm NHn+ s GPCR ligandom, R = 0,9873).
Rezultati istra`ivanja pokazali su razliku u eksperimentalnim i izra~unatim para-
metrima za TVAmesilat u usporedbi s PFX mesilatom i CIP hidrokloridom, te je na|ena
zna~ajna kolinearnost me|u ispitivanim parametrima ovih fluorokinolonskih antibiotika.
Klju~ne rije~i: fluorokionolonski antibiotici, trovafloksacin, pefloksacin, ciprofloksacin, 1H-NMR spek-
troskopija, 13C-NMR spektroskopija, molekulski opisiva~i, parametri sli~nosti s lijekovima, QSAR
Farmaceutsko-biokemijski fakultet Sveu~ili{ta u Zagrebu, Zagreb, Hrvatska
254
M. Jadrijevi}-Mladar Taka~: Effects of substituents on the NMR features of basic bicyclic ring systems of fluoroquinolone antibiotics
and the relationships between NMR chemical shifts, molecular descriptors and drug-likeness parameters, Acta Pharm. 60 (2010) 237–254.
